UCB's Global Corporate Website
Welcome to UCB in the United States


Find U.S. news and updates from UCB, a global biopharmaceutical company focused on creating value for people living with severe diseases, such as epilepsy, Parkinson’s disease, psoriasis, osteoporosis, myasthenia gravis,  rheumatoid arthritis, psoriatic arthritis, non-radiographic axial spondyloarthritis, and more. 

Spotlight Story

No results



UCB U.S. News

UCB's Commitment to Diversity, Equity, and Inclusion: Partnering at AES for a Better Future

Read More

Employee Spotlight: Stephen Mayclin’s Impact as a Working for Cures Champion and R&D Advocate

Read More

UCB Announces U.S. Availability of BIMZELX® for the Treatment of Adults with Moderate-to-Severe…

Read More

Twitter Feed

For More Information